244 related articles for article (PubMed ID: 26639637)
1. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
3. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.
Reinke DC; Starczak Y; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2018 Mar; 177():96-102. PubMed ID: 28765041
[TBL] [Abstract][Full Text] [Related]
4. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.
Kogawa M; Anderson PH; Findlay DM; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):277-80. PubMed ID: 20304055
[TBL] [Abstract][Full Text] [Related]
6. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
[TBL] [Abstract][Full Text] [Related]
7. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
9. Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.
Kogawa M; Findlay DM; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():59-61. PubMed ID: 22989483
[TBL] [Abstract][Full Text] [Related]
10. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro.
Boudiffa M; Wade-Gueye NM; Guignandon A; Vanden-Bossche A; Sabido O; Aubin JE; Jurdic P; Vico L; Lafage-Proust MH; Malaval L
J Bone Miner Res; 2010 Dec; 25(12):2669-79. PubMed ID: 20812227
[TBL] [Abstract][Full Text] [Related]
11. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
[TBL] [Abstract][Full Text] [Related]
13. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
14. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss.
Wu Y; Tworkoski K; Michaud M; Madri JA
J Immunol; 2009 Mar; 182(5):2672-9. PubMed ID: 19234161
[TBL] [Abstract][Full Text] [Related]
16. NLRC4 inflammasome has a protective role on inflammatory bone resorption in a murine model of periodontal disease.
Rocha FRG; Delitto AE; de Souza JAC; Maldonado LAG; Wallet SM; Rossa C
Immunobiology; 2020 Jan; 225(1):151855. PubMed ID: 31848028
[TBL] [Abstract][Full Text] [Related]
17. Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis.
Bloemen V; Schoenmaker T; de Vries TJ; Everts V
J Cell Physiol; 2010 Mar; 222(3):565-73. PubMed ID: 19927302
[TBL] [Abstract][Full Text] [Related]
18. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
19. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TRPV5 transcription and expression by E2/ERα signalling contributes to inhibition of osteoclastogenesis.
Song T; Lin T; Ma J; Guo L; Zhang L; Zhou X; Ye T
J Cell Mol Med; 2018 Oct; 22(10):4738-4750. PubMed ID: 30063124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
